KR20220148184A - 에리트로포이에틴 산생능이 항진된 섬유 아세포 - Google Patents

에리트로포이에틴 산생능이 항진된 섬유 아세포 Download PDF

Info

Publication number
KR20220148184A
KR20220148184A KR1020227030017A KR20227030017A KR20220148184A KR 20220148184 A KR20220148184 A KR 20220148184A KR 1020227030017 A KR1020227030017 A KR 1020227030017A KR 20227030017 A KR20227030017 A KR 20227030017A KR 20220148184 A KR20220148184 A KR 20220148184A
Authority
KR
South Korea
Prior art keywords
fibroblasts
epo
cells
cell
positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020227030017A
Other languages
English (en)
Korean (ko)
Inventor
타카히로 이와미야
Original Assignee
가부시키가이샤 메토세라
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가부시키가이샤 메토세라 filed Critical 가부시키가이샤 메토세라
Publication of KR20220148184A publication Critical patent/KR20220148184A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2304—Interleukin-4 (IL-4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/25—Tumour necrosing factors [TNF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020227030017A 2020-03-04 2021-03-04 에리트로포이에틴 산생능이 항진된 섬유 아세포 Withdrawn KR20220148184A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020036421 2020-03-04
JPJP-P-2020-036421 2020-03-04
PCT/JP2021/008325 WO2021177387A1 (ja) 2020-03-04 2021-03-04 エリスロポエチン産生能が亢進された線維芽細胞

Publications (1)

Publication Number Publication Date
KR20220148184A true KR20220148184A (ko) 2022-11-04

Family

ID=77614075

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227030017A Withdrawn KR20220148184A (ko) 2020-03-04 2021-03-04 에리트로포이에틴 산생능이 항진된 섬유 아세포

Country Status (9)

Country Link
US (1) US20220411761A1 (https=)
EP (1) EP4116412A4 (https=)
JP (2) JP7229618B2 (https=)
KR (1) KR20220148184A (https=)
CN (1) CN115210361B (https=)
AU (1) AU2021230209B2 (https=)
CA (1) CA3174551A1 (https=)
IL (1) IL296125A (https=)
WO (1) WO2021177387A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2023037868A1 (https=) * 2021-09-08 2023-03-16
WO2025135526A1 (ko) * 2023-12-19 2025-06-26 재단법인대구경북과학기술원 피부 또는 모발의 멜라닌 색소 조절용 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016006262A1 (ja) 2014-07-11 2016-01-14 貴紘 岩宮 心臓細胞培養材料
WO2018155651A1 (ja) 2017-02-24 2018-08-30 株式会社メトセラ 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101031B (pt) * 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
US6946246B1 (en) * 1997-04-08 2005-09-20 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Production of functional proteins: balance of shear stress and gravity
JP2004516820A (ja) 2000-08-25 2004-06-10 キュラジェン コーポレイション 新規タンパク質およびそれらのタンパク質をコードする核酸
JP5404951B2 (ja) 2008-04-22 2014-02-05 キヤノン株式会社 制御装置
KR101735125B1 (ko) 2008-11-12 2017-05-15 리젠메드 (케이만) 엘티디. 분리된 신장 세포 및 이의 용도
CN103154236B (zh) 2010-05-12 2016-08-31 再生医学Tx有限责任公司 生物活性肾细胞
CA3110831A1 (en) * 2018-08-29 2020-03-05 Metcela Inc. Method for producing fibroblast, and g-csf-positive fibroblast mass

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016006262A1 (ja) 2014-07-11 2016-01-14 貴紘 岩宮 心臓細胞培養材料
WO2018155651A1 (ja) 2017-02-24 2018-08-30 株式会社メトセラ 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
J Renal Inj Prev., 2013; 2(1): 29-30
Nephron, 1997; 77(2): 176-185
Proc Natl Acad Sci., 2004; 101(41): 14907-14912

Also Published As

Publication number Publication date
JPWO2021177387A1 (https=) 2021-09-10
JP2023053044A (ja) 2023-04-12
EP4116412A4 (en) 2024-04-03
CN115210361B (zh) 2024-12-10
AU2021230209B2 (en) 2025-01-30
JP7229618B2 (ja) 2023-02-28
EP4116412A1 (en) 2023-01-11
IL296125A (en) 2022-11-01
CN115210361A (zh) 2022-10-18
AU2021230209A1 (en) 2022-09-29
WO2021177387A1 (ja) 2021-09-10
US20220411761A1 (en) 2022-12-29
CA3174551A1 (en) 2021-09-10

Similar Documents

Publication Publication Date Title
Chang et al. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury
EP3551748B1 (en) Perinatal tissue derived mesenchymal stem cells: method of preparation and uses thereof
CN104321426A (zh) 永生化干细胞以及以其生成物为有效成分的药物组合物和药物制剂
CN110898078B (zh) 一种间充质干细胞分泌因子的制备及应用
TW201130977A (en) Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood
JP6883904B2 (ja) 線維芽細胞の製造方法及びｇ−ｃｓｆ陽性線維芽細胞集団
KR20080042761A (ko) 렙틴을 이용한 줄기세포 증식방법
JP2023053044A (ja) エリスロポエチン産生能が亢進された線維芽細胞
CN114901806A (zh) 细胞群以及其取得方法
JP2018530992A (ja) 間葉系幹細胞、そのクローン原性増殖方法、分離方法及び用途
JP2018530992A6 (ja) 間葉系幹細胞、そのクローン原性増殖方法、分離方法及び用途
US20240316113A1 (en) Fibroblast-containing pharmaceutical composition for treating kidney disease
JP2023001294A (ja) 臓器線維症の予防または治療剤
KR20230154177A (ko) 림프관 신생촉진인자 발현 섬유아세포 및 이를 포함하는의약 조성물
US20130244948A1 (en) Compositions of cells, media, and methods thereof
CN103977395A (zh) 生长因子制剂及其生产方法
CN113559125A (zh) 一种治疗糖尿病的干细胞药物
CN117919400A (zh) iPS诱导定向分化的成内皮祖细胞和抗体联合治疗心脑血管疾病
JP7506905B2 (ja) 添加剤
CN117120063A (zh) 淋巴管新生促进因子表达成纤维细胞以及含有该细胞的医药组合物
JP7627496B2 (ja) 心筋炎の治療剤
RU2800644C2 (ru) Способ получения фибробластов и г-ксф-положительная фибробластная масса
RU2742034C2 (ru) Бесклеточные терапевтические средства для регенеративной медицины и способы их получения
JP7473207B2 (ja) 末梢血流障害の治療剤
CN121759411A (zh) 过表达pdgf-bb的间充质干细胞及其用途

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

B11 Application withdrawn

Free format text: ST27 STATUS EVENT CODE: N-1-6-B10-B11-NAP-PC1202 (AS PROVIDED BY THE NATIONAL OFFICE)

PC1202 Submission of document of withdrawal before decision of registration

St.27 status event code: N-1-6-B10-B11-nap-PC1202